OmniAb Inc

OABINASDAQ · USD
4.74USD0.00 (0.00%)
3510

OmniAb Inc (OABI) Covered Calls

As of September 29, 2026, OABI has 4 covered call opportunities in the coming three months. Return ranges from 6.5 to 22.4% until expiration. Annualized return ranges from 29.3 to 132.6%. The nearest expiration is October 16, 2026. Maximum potential profit is $106.

Read more

Running OABI covered calls helps you generate consistent income from OmniAb Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on OmniAb Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best OABI covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if OABI stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling OABI covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given OmniAb Inc covered call is worth writing.

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets.

The company was founded in 2012 and is headquartered in Emeryville, California.

Income-focused investors, long-term OABI holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling OABI covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best OmniAb Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile35.32% Neutral
  • Market cap (M$)689
  • 52 weeks high-12.71%
  • 52 weeks low264.62%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$7.64
    61.18% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-03
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.36
  • EPS growth next 5 years43.10%

As of September 29, 2026

2026-10-16185.005.490.050.3531.006.54132.62-1.05+0.401,3110.30
2027-01-151095.005.490.801.00106.0022.3674.88-16.88+0.573,3940.20
2026-11-20535.005.490.200.9046.009.7066.83-4.22+0.5130.70
2027-04-162005.005.490.502.7576.0016.0329.26-10.55+0.66192.25

As of September 29, 2026

Sell covered calls with the data behind you

Find the best OABI covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial